Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

Traditional and new laboratory tools along with advances in AI are outlining a new paradigm in human disease modeling.

The study suggests that targeted brain stimulation could help bridge this gap. Academic learning has profound implications ...

Nearly 500 civil servants working at the EPA have signed an open letter to Administrator Zeldin in a Declaration of Dissent.

Researchers have uncovered new patterns of DNA damage associated with specific chemotherapy drugs to guide cancer treatment for less effects.

The new facility will combine academic innovation with industrial applications, catalyzing economic growth and training bioengineers.

Skin study findings may help to explain why African ancestry is associated with a lower risk of severe dengue.

A global microbiome preservation effort dubbed “Microbial Noah’s Ark” entered a new phase and announced the creation of ...

Researchers have uncovered how the breakdown of glycogen may protect the brain from neurodegeneration and Alzheimer's.

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...

Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...

A membrane transport protein called SLC13A5 has previously been linked to a severe form of epileptic encephalopathy.